vs
Side-by-side financial comparison of Bio-Techne (TECH) and Bristow Group Inc. (VTOL). Click either name above to swap in a different company.
Bristow Group Inc. is the larger business by last-quarter revenue ($377.3M vs $295.9M, roughly 1.3× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 4.9%, a 8.0% gap on every dollar of revenue. On growth, Bristow Group Inc. posted the faster year-over-year revenue change (6.7% vs -6.4%). Over the past eight quarters, Bristow Group Inc.'s revenue compounded faster (5.8% CAGR vs 4.2%).
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Bristow Helicopters Limited is a British civil helicopter operator originally based at Aberdeen Airport, Scotland, which is currently a part of the U.S.-based Bristow Group which in turn has its corporate headquarters in Houston, Texas, U.S. In 2020, Bristow Group was merged with Era Helicopters, a large U.S.-based commercial helicopter operator that was previously a division of Era Aviation, with the two companies then continuing to use the Bristow name.
TECH vs VTOL — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $377.3M |
| Net Profit | $38.0M | $18.4M |
| Gross Margin | 64.6% | — |
| Operating Margin | 18.4% | 8.5% |
| Net Margin | 12.8% | 4.9% |
| Revenue YoY | -6.4% | 6.7% |
| Net Profit YoY | 68.3% | -42.1% |
| EPS (diluted) | $0.24 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $295.9M | $377.3M | ||
| Q3 25 | — | $386.3M | ||
| Q2 25 | $317.0M | $376.4M | ||
| Q1 25 | $316.2M | $350.5M | ||
| Q4 24 | $297.0M | $353.5M | ||
| Q3 24 | $289.5M | $365.1M | ||
| Q2 24 | $306.1M | $359.7M | ||
| Q1 24 | $303.4M | $337.1M |
| Q4 25 | $38.0M | $18.4M | ||
| Q3 25 | — | $51.5M | ||
| Q2 25 | $-17.7M | $31.7M | ||
| Q1 25 | $22.6M | $27.4M | ||
| Q4 24 | $34.9M | $31.8M | ||
| Q3 24 | $33.6M | $28.2M | ||
| Q2 24 | $40.6M | $28.2M | ||
| Q1 24 | $49.1M | $6.6M |
| Q4 25 | 64.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 62.7% | — | ||
| Q1 25 | 67.9% | — | ||
| Q4 24 | 65.3% | — | ||
| Q3 24 | 63.2% | — | ||
| Q2 24 | 66.4% | — | ||
| Q1 24 | 67.4% | — |
| Q4 25 | 18.4% | 8.5% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | -7.5% | 11.3% | ||
| Q1 25 | 12.2% | 9.6% | ||
| Q4 24 | 16.0% | 9.0% | ||
| Q3 24 | 13.8% | 9.1% | ||
| Q2 24 | 15.0% | 12.4% | ||
| Q1 24 | 22.1% | 6.8% |
| Q4 25 | 12.8% | 4.9% | ||
| Q3 25 | — | 13.3% | ||
| Q2 25 | -5.6% | 8.4% | ||
| Q1 25 | 7.1% | 7.8% | ||
| Q4 24 | 11.7% | 9.0% | ||
| Q3 24 | 11.6% | 7.7% | ||
| Q2 24 | 13.3% | 7.8% | ||
| Q1 24 | 16.2% | 2.0% |
| Q4 25 | $0.24 | $0.61 | ||
| Q3 25 | — | $1.72 | ||
| Q2 25 | $-0.11 | $1.07 | ||
| Q1 25 | $0.14 | $0.92 | ||
| Q4 24 | $0.22 | $1.07 | ||
| Q3 24 | $0.21 | $0.95 | ||
| Q2 24 | $0.26 | $0.96 | ||
| Q1 24 | $0.31 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $172.9M | $286.2M |
| Total DebtLower is stronger | $260.0M | $671.5M |
| Stockholders' EquityBook value | $2.0B | $1.1B |
| Total Assets | $2.5B | $2.3B |
| Debt / EquityLower = less leverage | 0.13× | 0.63× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $172.9M | $286.2M | ||
| Q3 25 | — | $245.5M | ||
| Q2 25 | $162.2M | $251.8M | ||
| Q1 25 | $140.7M | $191.1M | ||
| Q4 24 | $177.5M | $247.5M | ||
| Q3 24 | $187.5M | $200.3M | ||
| Q2 24 | $152.9M | $178.6M | ||
| Q1 24 | $145.3M | $140.6M |
| Q4 25 | $260.0M | $671.5M | ||
| Q3 25 | — | $675.0M | ||
| Q2 25 | $346.0M | $705.2M | ||
| Q1 25 | $330.0M | $701.9M | ||
| Q4 24 | $300.0M | $689.8M | ||
| Q3 24 | $300.0M | $629.1M | ||
| Q2 24 | $319.0M | $594.2M | ||
| Q1 24 | $389.0M | $544.1M |
| Q4 25 | $2.0B | $1.1B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | $1.9B | $984.4M | ||
| Q1 25 | $2.0B | $931.7M | ||
| Q4 24 | $2.1B | $891.7M | ||
| Q3 24 | $2.1B | $899.2M | ||
| Q2 24 | $2.1B | $849.1M | ||
| Q1 24 | $2.0B | $820.7M |
| Q4 25 | $2.5B | $2.3B | ||
| Q3 25 | — | $2.3B | ||
| Q2 25 | $2.6B | $2.3B | ||
| Q1 25 | $2.6B | $2.2B | ||
| Q4 24 | $2.7B | $2.1B | ||
| Q3 24 | $2.7B | $2.1B | ||
| Q2 24 | $2.7B | $2.0B | ||
| Q1 24 | $2.7B | $1.9B |
| Q4 25 | 0.13× | 0.63× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | 0.18× | 0.72× | ||
| Q1 25 | 0.16× | 0.75× | ||
| Q4 24 | 0.14× | 0.77× | ||
| Q3 24 | 0.14× | 0.70× | ||
| Q2 24 | 0.15× | 0.70× | ||
| Q1 24 | 0.19× | 0.66× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $76.9M |
| Free Cash FlowOCF − Capex | — | $47.8M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 7.7% |
| Cash ConversionOCF / Net Profit | — | 4.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | $56.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $76.9M | ||
| Q3 25 | — | $23.1M | ||
| Q2 25 | $98.2M | $99.0M | ||
| Q1 25 | $41.1M | $-603.0K | ||
| Q4 24 | $84.3M | $51.1M | ||
| Q3 24 | $63.9M | $66.0M | ||
| Q2 24 | $75.5M | $33.7M | ||
| Q1 24 | $81.0M | $26.7M |
| Q4 25 | — | $47.8M | ||
| Q3 25 | — | $-6.2M | ||
| Q2 25 | $93.3M | $67.4M | ||
| Q1 25 | $31.0M | $-52.7M | ||
| Q4 24 | $77.5M | $-32.4M | ||
| Q3 24 | $54.7M | $9.0M | ||
| Q2 24 | $57.5M | $-16.7M | ||
| Q1 24 | $64.5M | $-37.9M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | -1.6% | ||
| Q2 25 | 29.4% | 17.9% | ||
| Q1 25 | 9.8% | -15.0% | ||
| Q4 24 | 26.1% | -9.2% | ||
| Q3 24 | 18.9% | 2.5% | ||
| Q2 24 | 18.8% | -4.6% | ||
| Q1 24 | 21.3% | -11.2% |
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | 7.6% | ||
| Q2 25 | 1.5% | 8.4% | ||
| Q1 25 | 3.2% | 14.9% | ||
| Q4 24 | 2.3% | 23.6% | ||
| Q3 24 | 3.2% | 15.6% | ||
| Q2 24 | 5.9% | 14.0% | ||
| Q1 24 | 5.4% | 19.2% |
| Q4 25 | — | 4.17× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 3.12× | ||
| Q1 25 | 1.82× | -0.02× | ||
| Q4 24 | 2.42× | 1.61× | ||
| Q3 24 | 1.90× | 2.34× | ||
| Q2 24 | 1.86× | 1.20× | ||
| Q1 24 | 1.65× | 4.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
VTOL
| Offshore Energy Services | $247.5M | 66% |
| Government Services | $100.1M | 27% |
| Other | $21.9M | 6% |
| Related Party | $7.8M | 2% |
